120 related articles for article (PubMed ID: 6442861)
21. Estrone-3-glucuronide chemiluminescence immunoassay: an alternative method for monitoring induction of ovulation with human menopausal gonadotropin in an in vitro fertilization program.
Lessing JB; Peyser MR; Gilad S; Amit A; Kogosowski A; Yovel I; Barak Y; David MP
Fertil Steril; 1987 Sep; 48(3):450-3. PubMed ID: 3114012
[TBL] [Abstract][Full Text] [Related]
22. Comparative study of oestrogen excretion in female New World Monkeys: an overview of non-invasive ovarian monitoring and a new application in evolutionary biology.
Pryce CR; Schwarzenberger F; Döbeli M; Etter K
Folia Primatol (Basel); 1995; 64(3):107-23. PubMed ID: 8529968
[TBL] [Abstract][Full Text] [Related]
23. Pre-ovulatory plasma levels of 17beta-oestradiol (E2) and conception in patients treated with gonadotrophins.
Ferin J; Thomas K; De Hertogh R
Acta Endocrinol Suppl (Copenh); 1977; 214():33-42. PubMed ID: 268747
[TBL] [Abstract][Full Text] [Related]
24. The direct radioimmunoassay of oestrogen glucuronides in human female urine.
Baker TS; Jennison KM; Kellie AE
Biochem J; 1979 Feb; 177(2):729-38. PubMed ID: 435263
[TBL] [Abstract][Full Text] [Related]
25. The concentrations of urinary oestrone-3-glucuronide, LH and pregnanediol-3alpha-glucuronide as indices of ovarian function.
Collins WP; Collins PO; Kilpatrick MJ; Manning PA; Pike JM; Tyler JP
Acta Endocrinol (Copenh); 1979 Feb; 90(2):336-48. PubMed ID: 419920
[TBL] [Abstract][Full Text] [Related]
26. Comparative pharmacokinetics of oestradiol, oestrone, oestrone sulfate and "conjugated oestrogens" after oral administration.
Schindler AE; Bolt HM; Zwirner M; Hochlehnert G; Göser R
Arzneimittelforschung; 1982; 32(7):787-91. PubMed ID: 6289846
[TBL] [Abstract][Full Text] [Related]
27. Monitoring of ovarian activity by daily measurement of urinary excretion rates of oestrone glucuronide and pregnanediol glucuronide using the Ovarian Monitor, Part III: variability of normal menstrual cycle profiles.
Blackwell LF; Vigil P; Cooke DG; d'Arcangues C; Brown JB
Hum Reprod; 2013 Dec; 28(12):3306-15. PubMed ID: 24170744
[TBL] [Abstract][Full Text] [Related]
28. Factors influencing the pregnancy and complication rates with human menopausal gonadotrophin therapy.
Ellis JD; Williamson JG
Br J Obstet Gynaecol; 1975 Jan; 82(1):52-7. PubMed ID: 1138820
[TBL] [Abstract][Full Text] [Related]
29. Induction of ovulation with human menopausal gonadotrophin.
Ho PC; Tang LC; Tang GW
Asia Oceania J Obstet Gynaecol; 1984 Sep; 10(3):325-31. PubMed ID: 6441552
[No Abstract] [Full Text] [Related]
30. Pattern of excretion of urinary steroid metabolites during the ovarian cycle and pregnancy in the marmoset monkey.
Eastman SA; Makawiti DW; Collins WP; Hodges JK
J Endocrinol; 1984 Jul; 102(1):19-26. PubMed ID: 6330265
[TBL] [Abstract][Full Text] [Related]
31. Interpretation of urinary oestrogen:creatinine ratio for monitoring fetoplacental function in late pregnancy.
Phillips SD; Salway JG; Payne RB; Macdonald HN
Clin Chim Acta; 1978 Oct; 89(1):71-8. PubMed ID: 709869
[TBL] [Abstract][Full Text] [Related]
32. A prospective study of urinary oestrogen excretion and breast cancer risk.
Key TJ; Wang DY; Brown JB; Hermon C; Allen DS; Moore JW; Bulbrook RD; Fentiman IS; Pike MC
Br J Cancer; 1996 Jun; 73(12):1615-9. PubMed ID: 8664140
[TBL] [Abstract][Full Text] [Related]
33. A comparison of 2 methods for monitoring gonadotrophin therapy.
Sallam HN; Bashmi YA
Aust N Z J Obstet Gynaecol; 1989 May; 29(2):160-4. PubMed ID: 2508610
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of ovulation by low-dose mifepristone (RU 486).
Ledger WL; Sweeting VM; Hillier H; Baird DT
Hum Reprod; 1992 Aug; 7(7):945-50. PubMed ID: 1331167
[TBL] [Abstract][Full Text] [Related]
35. Monitoring ovulation and implantation in the lion-tailed macaque (Macaca silenus) through urinary estrone conjugate evaluations.
Shideler SE; Czekala NM; Kasman LH; Lindburg DG; Lasley BL
Biol Reprod; 1983 Nov; 29(4):905-11. PubMed ID: 6640039
[TBL] [Abstract][Full Text] [Related]
36. Studies on the influence of gonadotrophin levels in the early follicular phase on the ovarian response to stimulation.
Forman RG; Demouzon J; Feinstein MC; Testart J; Frydman R
Hum Reprod; 1991 Jan; 6(1):113-7. PubMed ID: 1908489
[TBL] [Abstract][Full Text] [Related]
37. Comparison of urinary oestrogen excretion in South American primates.
Hodges JK; Gulick BA; Czekala NM; Lasley BL
J Reprod Fertil; 1981 Jan; 61(1):83-90. PubMed ID: 6779005
[TBL] [Abstract][Full Text] [Related]
38. Periovulatory 17 beta-estradiol pattern in conceptional and nonconceptional cycles during menotropin treatment of anovulatory infertility.
Navot D; Margalioth EJ; Laufer N; Brzezinski A; Birkenfeld A; Schenker JG
Fertil Steril; 1987 Feb; 47(2):234-7. PubMed ID: 3102283
[TBL] [Abstract][Full Text] [Related]
39. Ovulation induction with human menopausal gonadotrophins: an evaluation of a variable daily dosage regimen.
Webb-Wilson GJ; Arronet GH
Int J Fertil; 1977; 22(4):225-31. PubMed ID: 24600
[TBL] [Abstract][Full Text] [Related]
40. The OVEIA assay, a simultaneous measurement of oestrone and pregnanediol glucuronides, for studying the treatment of infertility patients.
Anthony F; Aldrich C; Sharp NC; Smith EM; Masson GM; Dennis KJ
Hum Reprod; 1988 Oct; 3(7):870-2. PubMed ID: 3182977
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
